Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Analyst Downgrades, and What Investors Watch Next (Dec. 22, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Analyst Downgrades, and What Investors Watch Next (Dec. 22, 2025)

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is trading like a classic “deal stock” on December 22, 2025—hovering just below a fixed cash acquisition price after BioMarin Pharmaceutical (NASDAQ: BMRN) agreed to buy the company in an all-cash transaction. As of the
Uber Technologies (UBER) Stock Rallies on Baidu Robotaxi London Deal: Today’s News, Analyst Forecasts, and 2026 Outlook (Dec. 22, 2025)

Uber Technologies (UBER) Stock Rallies on Baidu Robotaxi London Deal: Today’s News, Analyst Forecasts, and 2026 Outlook (Dec. 22, 2025)

December 22, 2025 — Uber Technologies, Inc. (NYSE: UBER) is back in the spotlight after a fresh autonomous-vehicle headline reignited a debate that has been shadowing the stock for months: are robotaxis a future profit engine for Uber—or the “existential
Go toTop